Protocol summary
-
Study aim
-
The aim of this study is to determine the effects of selenium supplementation on insulin insulin and inflammatory factor in women with polycystic ovary syndrome (PCOS).
-
Design
-
Study design: parallel double-blind randomized controlled clinical trial.
-
Settings and conduct
-
Population and sample size: 70 women with PCOS eligible and referred to Kossar Clinic affiliated to Arak University of Medical Sciences, Arak, Iran in the study will be selected.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients with PCOS according to Rotterdam criteria and aged 18 to 40 years will be included in this study. Exclusion criteria: Menopause, consumed selenium supplements and metformin in the last 3 months, diabetic, hypothyroidism, used tobacco, taking a special diet or effective drugs on hormonal profile like oral conceptive (OCP) and ovulation induction agents.
-
Intervention groups
-
Intervention: Patients will be assigned to receive either 200 µg selenium supplement (intervention group: n=35) or placebo (control group: n=35).
-
Main outcome variables
-
Insulin resistance (primary outcome) and lipid profiles (secondary outcome) will be quantified at study baseline and end-of-trial.
General information
-
Reason for update
-
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT201408155623N25
Registration date:
2014-08-24, 1393/06/02
Registration timing:
registered_while_recruiting
Last update:
2019-09-28, 1398/07/06
Update count:
1
-
Registration date
-
2014-08-24, 1393/06/02
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
Arak University of Medical Sciences
-
Expected recruitment start date
-
2014-08-12, 1393/05/21
-
Expected recruitment end date
-
2014-08-26, 1393/06/04
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Effects of selenium supplementation on insulin metabolism and lipid profiles in women with polycystic ovary syndrome
-
Public title
-
Effect of supplementation in treatment of polycystic ovary syndrome
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Women aged 18-40 years
Diagnosed with PCOS
Exclusion criteria:
Menopause
Consumed selenium supplements and metformin in the last 3 months
Diabetic
Hypothyroidism
Used tobacco
Taking a special diet or effective drugs on hormonal profile like oral conceptive (OCP) and ovulation induction agents.
-
Age
-
From 18 years old to 40 years old
-
Gender
-
Female
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Investigator
- Outcome assessor
-
Sample size
-
Target sample size:
70
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
At study baseline and after stratification for pre-intervention BMI and age, subjects will be randomly divided into two groups to take either selenium supplements (n=35) or placebo (n=35). Randomization will be done by the use of computer-generated random numbers.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
Participants, investigators or the assessors of the outcomes are unaware of the study groups.
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2014-08-11, 1393/05/20
-
Ethics committee reference number
-
93-166-18
Health conditions studied
1
-
Description of health condition studied
-
Polycystic ovary syndrome
-
ICD-10 code
-
E28.2
-
ICD-10 code description
-
Sclerocystic ovary syndrome Stein-Leventhal syndrome
Primary outcomes
1
-
Description
-
Insulin resistance
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Eliza
Secondary outcomes
1
-
Description
-
Insulin
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Elisa kit
2
-
Description
-
Insulin sensitivity
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Using QUICKI formula
3
-
Description
-
Triglycerides
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Enzymatic kit
4
-
Description
-
Total cholesterol
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Enzymatic kit
5
-
Description
-
VLDL
-
Timepoint
-
At the beginning of the study and after 8 weeks of intervention
-
Method of measurement
-
Enzymatic kit
6
-
Description
-
LDL-cholesterol
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Elisa kit
7
-
Description
-
HDL-cholesterol
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
Intervention groups
1
-
Description
-
Intervention group: Selenium tablet, 200 µg, daily, for 8 weeks orally.
-
Category
-
Treatment - Drugs
2
-
Description
-
Control group: Placebo tablet, daily, for 8 weeks orally.
-
Category
-
Treatment - Drugs
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Arak University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available